Literature DB >> 25867960

The forced swim test as a model of depressive-like behavior.

Roni Yankelevitch-Yahav1, Motty Franko2, Avrham Huly2, Ravid Doron3.   

Abstract

The goal of the present protocol is to describe the forced swim test (FST), which is one of the most commonly used assays for the study of depressive-like behavior in rodents. The FST is based on the assumption that when placing an animal in a container filled with water, it will first make efforts to escape but eventually will exhibit immobility that may be considered to reflect a measure of behavioral despair. This test has been extensively used because it involves the exposure of the animals to stress, which was shown to have a role in the tendency for major depression. Additionally, the FST has been shown to share some of the factors that are influenced or altered by depression in humans, including changes in food consumption, sleep abnormalities and drug-withdrawal-induced anhedonia. The main advantages of this procedure are that it is relatively easy to perform and that its results are easily and quickly analyzed. Moreover, its sensitivity to a broad range of antidepressant drugs that makes it a suitable screening test is one of the most important features leading to its high predictive validity. Despite its appeal, this model has a number of disadvantages. First, the issue of chronic augmentation is problematic in this test because in real life patients need to be treated for at least several weeks before they experience any relief from their symptoms. Last, due to the aversiveness of the FST, it is important to take into account possible influences it might have on brain structure/function if brain analyses are to be carried out following this procedure.

Entities:  

Mesh:

Year:  2015        PMID: 25867960      PMCID: PMC4401172          DOI: 10.3791/52587

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  57 in total

1.  Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.

Authors:  John F Cryan; Daniel Hoyer; Athina Markou
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

Review 2.  Pharmacological treatment of generalized anxiety disorder.

Authors:  Jennifer A Reinhold; Laura A Mandos; Karl Rickels; Falk W Lohoff
Journal:  Expert Opin Pharmacother       Date:  2011-09-28       Impact factor: 3.889

3.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

4.  An immnosuppressive drug, cyclosporine-A acts like anti-depressant for rats under unpredictable chronic stress.

Authors:  Chieko Fujisaki; Masanori Utsuyama; Yasukazu Kuroda; Akiko Watanabe; Heinrich Seidler; Shigeru Watanabe; Masanobu Kitagawa; Katsuiku Hirokawa
Journal:  J Med Dent Sci       Date:  2003-03

5.  Learned immobility explains the behavior of rats in the forced swimming test.

Authors:  J M De Pablo; A Parra; S Segovia; A Guillamón
Journal:  Physiol Behav       Date:  1989-08

6.  Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats.

Authors:  W P Paré
Journal:  Physiol Behav       Date:  1994-03

7.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

Review 8.  Evidence-based strategies for achieving and sustaining full remission in depression: focus on metaanalyses.

Authors:  Raymond W Lam; Sidney H Kennedy
Journal:  Can J Psychiatry       Date:  2004-03       Impact factor: 4.356

9.  Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.

Authors:  R Bordet; P Thomas; B Dupuis
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

Review 10.  In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice.

Authors:  J F Cryan; C Mombereau
Journal:  Mol Psychiatry       Date:  2004-04       Impact factor: 15.992

View more
  123 in total

1.  Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.

Authors:  Indrani Datta; S R Mekha; Alka Kaushal; Kavina Ganapathy; Rema Razdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-29       Impact factor: 3.000

2.  Acid Sphingomyelinase Inhibition Mitigates Histopathological and Behavioral Changes in a Murine Model of Traumatic Brain Injury.

Authors:  Grace M Niziolek; Ryan M Boudreau; Jennifer Baker; Lou Ann Friend; Amy T Makley; Michael J Edwards; Erich Gulbins; Michael D Goodman
Journal:  J Neurotrauma       Date:  2020-05-04       Impact factor: 5.269

3.  High-Salt Exposure During Perinatal Development Enhances Stress Sensitivity.

Authors:  Paige M Dingess; Amit Thakar; Zhaojie Zhang; Francis W Flynn; Travis E Brown
Journal:  Dev Neurobiol       Date:  2018-08-29       Impact factor: 3.964

Review 4.  A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.

Authors:  Stacey L Robinson; Todd E Thiele
Journal:  Neuropharmacology       Date:  2020-02-03       Impact factor: 5.250

5.  Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats.

Authors:  Seungwoo Kang; Jing Li; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2017-11-08       Impact factor: 5.250

6.  The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice.

Authors:  Or Burstein; Ravid Doron
Journal:  J Vis Exp       Date:  2018-10-24       Impact factor: 1.355

7.  CD36 deficiency reduces chronic BBB dysfunction and scar formation and improves activity, hedonic and memory deficits in ischemic stroke.

Authors:  Mustafa Balkaya; Il-Doo Kim; Faariah Shakil; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-13       Impact factor: 6.200

8.  Genipin normalizes depression-like behavior induced by prenatal stress through inhibiting DNMT1.

Authors:  Di Ye; Li Zhang; Weidong Fan; Xianquan Zhang; Erbo Dong
Journal:  Epigenetics       Date:  2018-05-03       Impact factor: 4.528

9.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

10.  Chronic postnatal chemogenetic activation of forebrain excitatory neurons evokes persistent changes in mood behavior.

Authors:  Kamal Saba; Sonali S Salvi; Sthitapranjya Pati; Praachi Tiwari; Pratik R Chaudhari; Vijaya Verma; Sourish Mukhopadhyay; Darshana Kapri; Shital Suryavanshi; James P Clement; Anant B Patel; Vidita A Vaidya
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.